TXR 612
Alternative Names: TXR-612Latest Information Update: 11 May 2021
At a glance
- Originator twoXAR
- Developer Aria Pharmaceuticals
- Class Hepatoprotectants; Small molecules
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Non-alcoholic steatohepatitis